Cargando…
A mouse model of heterogeneous, c-MYC-initiated prostate cancer with loss of Pten and p53
Human tumors are heterogeneous and evolve through a dynamic process of genetic mutation and selection. During this process, the effects of a specific mutation on the incipient cancer cell may dictate the nature of subsequent mutations that can be tolerated or selected for, affecting the rate at whic...
Autores principales: | Kim, Jongchan, Roh, Meejeon, Doubinskaia, Irina, Algarroba, Gabriela N., Eltoum, Isam-Eldin A., Abdulkadir, Sarki A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3179816/ https://www.ncbi.nlm.nih.gov/pubmed/21685943 http://dx.doi.org/10.1038/onc.2011.236 |
Ejemplares similares
-
Interactions between Cells with Distinct Mutations in c-MYC and Pten in Prostate Cancer
por: Kim, Jongchan, et al.
Publicado: (2009) -
Pim1 promotes human prostate cancer cell tumorigenicity and c-MYC transcriptional activity
por: Kim, Jongchan, et al.
Publicado: (2010) -
Pim1 kinase synergizes with c-MYC to induce advanced prostate carcinoma
por: Wang, Jie, et al.
Publicado: (2010) -
Pim1 kinase is required to maintain tumorigenicity in MYC-expressing prostate cancer cells
por: Wang, Jie, et al.
Publicado: (2011) -
Bmi1 marks distinct castration-resistant luminal progenitor cells competent for prostate regeneration and tumour initiation
por: Yoo, Young A., et al.
Publicado: (2016)